-
Mashup Score: 55Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden - 1 year(s) ago
Cardiovascular autonomic dysfunction (CVAD) is a malfunction of the cardiovascular system caused by deranged autonomic control of circulatory homeostasis. CVAD is an important component of post-COVID-19 syndrome, also termed long COVID, and might affect one-third of highly symptomatic patients with COVID-19. The effects of CVAD can be seen at both the whole-body level, with impairment of heart…
Source: www.nature.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 6
The 3rd annual educational virtual event put together by the four Northern Local Clinical Research Networks
Source: www.eventbrite.co.ukCategories: General Medicine News, CardiologistsTweet-
I’ll be chairing the @NIHRcommunity CVD Northern Educational Engagement Event on 14th February 2024 ❤️🩹. Including @TheBHF & a series of excellent speakers. Register via the link & learn about the great things we are doing in #cardiovascular research! https://t.co/qfJycJnk4o https://t.co/0vw2YGzEDu
-
-
Mashup Score: 4Mosaic loss of chromosome Y and cardiovascular disease - 1 year(s) ago
Mosaic loss of chromosome Y (mLOY) refers to the condition in male individuals in which a detectable fraction of cells lose the Y chromosome. Prevalent in haematopoietic cells, this common somatic mutation is associated with decreased longevity and an increased risk of age-related diseases, including cardiovascular disease. Haematopoietic mLOY provides further insight into the sex-specific…
Source: www.nature.comCategories: General Medicine News, Cardiology News and JournTweet-
In a new Comment article, Sano & Walsh discuss the link between mosaic loss of chromosome Y and #cardiovascular disease: https://t.co/JMB85jFGeB https://t.co/tmtn0MZrL3
-
-
Mashup Score: 6
Commentary on: Alahmad B, Khraishah H, Royé D, Vicedo-Cabrera AM, Guo Y, Papatheodorou SI, Achilleos S, Acquaotta F, Armstrong B, Bell ML, Pan SC, de Sousa Zanotti Stagliorio Coelho M, Colistro V, Dang TN, Van Dung D, De’ Donato FK, Entezari A, Guo YL, Hashizume M, Honda Y, Indermitte E, Íñiguez C, Jaakkola JJK, Kim H, Lavigne E, Lee W, Li S, Madureira J, Mayvaneh F, Orru H, Overcenco A, Ragettli MS, Ryti NRI, Saldiva PHN, Scovronick N, Seposo X, Sera F, Silva SP, Stafoggia M, Tobias A, Garshick E, Bernstein AS, Zanobetti A, Schwartz J, Gasparrini A, Koutrakis P. Associations Between Extreme Temperatures and Cardiovascular Cause-Specific Mortality: Results From 27 Countries. Circulation . 2023 Jan 3;147(1):35-46. doi: 10.1161/CIRCULATIONAHA.122.061832. Epub 2022 Dec 12. Extremes in ambient temperature are associated with excess deaths. For example, more than 60 000 excess …
Source: ebn.bmj.comCategories: General Medicine News, NursingTweet-
🔥🌡️ Stay aware, nurses! Extreme temperatures, be it hot or cold, are linked to higher #cardiovascular mortality rates. Check out this hot off the press commentary article by @barrett1972 👀🔍 Read it here 🔗 https://t.co/3RwYFYP0jf https://t.co/yQQ6XTRspx
-
-
Mashup Score: 6
Commentary on: Alahmad B, Khraishah H, Royé D, Vicedo-Cabrera AM, Guo Y, Papatheodorou SI, Achilleos S, Acquaotta F, Armstrong B, Bell ML, Pan SC, de Sousa Zanotti Stagliorio Coelho M, Colistro V, Dang TN, Van Dung D, De’ Donato FK, Entezari A, Guo YL, Hashizume M, Honda Y, Indermitte E, Íñiguez C, Jaakkola JJK, Kim H, Lavigne E, Lee W, Li S, Madureira J, Mayvaneh F, Orru H, Overcenco A, Ragettli MS, Ryti NRI, Saldiva PHN, Scovronick N, Seposo X, Sera F, Silva SP, Stafoggia M, Tobias A, Garshick E, Bernstein AS, Zanobetti A, Schwartz J, Gasparrini A, Koutrakis P. Associations Between Extreme Temperatures and Cardiovascular Cause-Specific Mortality: Results From 27 Countries. Circulation . 2023 Jan 3;147(1):35-46. doi: 10.1161/CIRCULATIONAHA.122.061832. Epub 2022 Dec 12. Extremes in ambient temperature are associated with excess deaths. For example, more than 60 000 excess …
Source: ebn.bmj.comCategories: General Medicine News, NursingTweet-
🔥🌡️ Stay aware, nurses! Extreme temperatures, be it hot or cold, are linked to higher #cardiovascular mortality rates. Check out this hot off the press commentary article by @barrett1972 👀🔍 Read it here 🔗 https://t.co/3RwYFYP0jf https://t.co/yQQ6XTRspx
-
-
Mashup Score: 43DCRI to Partner with Novo Nordisk on Large-Scale Global Cardiovascular Study in Acute Myocardial Infarction - DCRI - 2 year(s) ago
November 11, 2023 – By randomizing 10,000 adult patients, ARTEMIS will evaluate the effects of a study medicine versus placebo on cardiovascular outcomes in patients with acute myocardial infarction. Novo Nordisk, in collaboration with the Duke Clinical Research Institute (DCRI), will initiate a global cardiovascular outcomes study called ARTEMIS. The ARTEMIS study will be conducted […]
Source: dcri.orgCategories: General Medicine News, CardiologistsTweet-
An important next step in addressing the inflammatory hypothesis in #cardiovascular disease @DCRINews to Partner with Novo Nordisk on Large-Scale Global Cardiovascular Study in Acute MI @jennifer_rymer @Drroxmehran https://t.co/7WZseLEjH0
-
-
Mashup Score: 2
There was a J-shaped association of FT4 with cardiovascular disease and mortality. Low concentrations of TSH were associated with a higher risk of all-cause mortality and cardiovascular disease mortality. The 20–40th percentiles of FT4 and the 60–80th percentiles of TSH could represent the optimal healthy ranges of thyroid function based on the risk of cardiovascular disease and mortality, with more than 5% increase of 10-year composite risk identified for FT4 greater than the 85th percentile in women and men older than 70 years.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
The optimal healthy ranges of #thyroid function defined by the risk of #cardiovascular disease and mortality: systematic review and individual participant data meta-analysis https://t.co/ml2Gfq4B3N #CVD
-
-
Mashup Score: 0FDA clears next-gen image-guided therapy tech from GE HealthCare - 2 year(s) ago
GE HealthCare announced today that the FDA granted 510(k) clearance to its Allia IGS Pulse system.
Source: www.massdevice.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
#FDA clears next-gen #imageguidedtherapy #IGT tech from @GEHealthCare | #cardiovascular https://t.co/mgBBK2HqAb https://t.co/F2a9zbr8hx
-
-
Mashup Score: 0What's next for Abbott's cardiovascular business? - 2 year(s) ago
Abbott boosted its vascular device offerings even more with its acquisition of Cardiovascular Systems. Find out more at DeviceTalks West.
Source: www.massdevice.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
What’s next for @AbbottCardio #cardiovascular business? | #medicaldevices https://t.co/NI3CM6mn6W
-
-
Mashup Score: 1Arineta announces SpotLight Duo - 2 year(s) ago
October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT (CCT) scanners. The two products extend Arineta’s leadership as the only dedicated cardiovascular CT system, and the Duo system adds high resolution thoracic clinical capability, including for lung cancer, COVID19, and other pulmonary diseases. Both the SpotLight and SpotLight Duo systems add extended coverage for peripheral vascular and runoff studies, a rapidly growing procedure for vascular therapies. “Arineta has been the leader in cardiovascular CT technology, and the new SpotLight systems continue Arineta’s history of clinical innovation,” said Scott Schubert, Arineta CEO. “Our vision is to grow cardiac CT as the front-line non-invasive test for diagnosing, therapy planning and monitoring of cardiovascular disease- the number one cause of death and costs for healthcare worldwide.” “The recent change in guidelines from the ACC
Source: www.dicardiology.comCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @ArinetaCardio #Arineta #CardiacImaging announced the #FDA 510(k) clearance of the #SpotLight and #SpotLightDuo family of #cardiovascular #CT (#CCT) scanners: https://t.co/Qj3RE4Th7Z
-
In a new Review, Fedorowski and colleagues describe #cardiovascular autonomic dysfunction in post-COVID-19 syndrome and how this major health-care burden can be diagnosed and managed: https://t.co/aJWN2nT5kM https://t.co/0rCphi8gQw